The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2019
Filed:
Apr. 06, 2015
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Jagath R. Junutula, Fremont, CA (US);
William Mallet, Redwood City, CA (US);
Assignee:
Genentech, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2005.12); C12P 21/08 (2005.12); C07K 16/28 (2005.12); A61K 47/68 (2016.12); A61K 51/10 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/28 (2012.12); A61K 47/6803 (2017.07); A61K 47/6849 (2017.07); A61K 51/1027 (2012.12); A61K 2039/505 (2012.12); C07K 2317/624 (2012.12); C07K 2317/71 (2012.12); C07K 2317/72 (2012.12); C07K 2319/55 (2012.12);
Abstract
Cysteine engineered anti-MUC16 antibodies are engineered by replacing one or more amino acids of a parent anti-MUC16 antibody with non cross-linked, reactive cysteine amino acids. Methods of design, preparation, screening, and selection of the cysteine engineered anti-MUC16 antibodies are provided. Cysteine engineered anti-MUC16 antibodies (Ab) are conjugated with one or more drug moieties (D) through a linker (L) to form cysteine engineered anti-MUC16 antibody-drug conjugates having Formula I:Ab-(L-D)  I